Mankind Pharma shares rise 10% after strong Q2 results

Mankind Pharma's shares rose 10% in today's market session after the company reported a 33% increase in exports in Q2. The company's income from operations rose 17.3% to Rs. 4,338 crore, and EBITDA increased 27.2% to Rs. 1,175 crore.

The company's revenue rose 14.8% in India and 32.7% through exports. Domestic pharmaceuticals and exports were the main contributors to revenue growth, while consumer healthcare revenue increased only slightly.